For R&D use only.

Crizotinib

  • Catalog NO.:A10455
  • CAS No. : 877399-52-5
  • Molecular Formula:C21H22Cl2FN5O
  • Molecular Weight: 450.34
Note*
1. Please click the  to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Bulk Inquiry
Quality Control&SDS
SDS COA HPLC/GC NMR

Product Details

CAS Number 877399-52-5 Appearance White powder
Catalog Number A10455 MDL Number MFCD12407409
Molecular Formula C21H22Cl2FN5O Molecular Weight 450.34
Boiling Point Melting Point 197-203°C
Flash Point Density 1.475
Synonyms PF 2341066; Crizotinib;3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-Pyridinamine
Storage Condition Store in a tightly closed container,in a cool and dry place

Safety

GHS Pictogram
Signal Word Warning UN Number Not hazmat
Hazard Statements H317; H319; H341; H400 Class
Precautionary Statements P201; P202; P261; P264; P272; P273; P280; P281; P302+P352; P305+P351+P338; P308+ P313; P333+P313; P337+P313; P363; P391; P405; P501 Packing Group

Description

Crizotinib, also known as PF-02341066, is an orally bioavailable agent belonging to the class of c-met/hepatocyte growth factor receptor (HGFR) tyrosine kinase inhibitors with potential antineoplastic activity. Crizotinib was approved for treatment of some non-small cell lung carcinoma (NSCLC) in the US, and undergoing clinical trials testing its safety and efficacy in anaplastic large cell lymphoma, neuroblastoma, and other advanced solid tumors in both adults and childre. Crizotinib inhibits the membrane receptor MET and activation of the MET signaling pathway, which may block tumor cell growth, migration and invasion, and tumor angiogenesis in susceptible tumor cell populations. Crizotinib was approved in 2011.

877399-53-6 (acetate)

877399-52-5 (free base)

Related Products

My Tracks: Crizotinib
Batch search Close
Batch processing can be done by CAS number, CAS number, one search per line
...

Crizotinib
PF 2341066; Crizotinib;3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-Pyridinamine